EBX-205

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEBX-205
Drug Alias NameEV 035 series - Emergent BioSolutions2-pyridone based topoisomerase inhibitors (EV-035)anti-infectives - Emergent BioSolutionsEBX-205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsInfluenza, HumanMycosesStaphylococcal Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc
Inactive CompaniesN/A
Active IndicationsInfluenza, HumanMycosesStaphylococcal Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A